
U.S. Securities and Exchange Commission
August 20, 2018
Page 2
1. | We note your disclosure that your accounts receivable balance as of November 30, 2017 was overstated by approximately $2.4 million. Please clarify for us whether this overstatement had a similar impact on revenues and excess of revenues over expenses for the period ended November 30, 2017. Additionally, please tell us whether the correction of this overstatement during the period ended May 31, 2018 had any impact on revenues and the excess of revenues over expenses. |
Response
In response to the Staff’s comment regarding the $2.4 million overstatement of accounts receivable as of November 30, 2017, the Company wishes to advise the Staff of the following clarification.
The Company accounts for the redemption of free night vouchers through a series of journal entries. Upon redemption, the first entry reduces the free night voucher liability with an offset to program cost of sales expense. The second entry records the reduction of accounts receivable for the member where the voucher was redeemed, with an offset to program cost of sales expense. During the second quarter 2018 close process, the Company identified a reoccurring one-month lag in the second entry, which resulted in accounts receivable being overstated, program cost of sales being understated and excess of revenues over expenses being overstated at period end. The Company notes that for any given period, the effect of the reoccurring error is minimized due to the rollover impact of the prior period. There is no impact on revenues in any given period.
The Company analyzed the impact of the error and for 2017, the November 30, 2017 accounts receivable balance was overstated by $2.4 million, program cost of sales expense was understated by $1 million (based on the rollover impact of the prior period), and excess of revenues over expenses was overstated by $1 million.
The Company evaluated the error under SAB 99 and SAB 108 and determined that the error was immaterial to both current and prior periods, as a result of the rollover impact, and corrected the error in the balance sheet at May 31, 2018. This correction resulted in an overstatement of program cost of sales expense for the 6-month period ended May 31, 2018 of $2.4 million.
To clarify this matter in our financial statements, the Company proposes adding the bold and underlined disclosure to the notes to our financial statements included in the Registration Statement on page F-8, paragraph 3:
(k) Significant Estimates and Assumptions